IMACX
Price
$9.83
Change
-$0.11 (-1.11%)
Updated
Sep 20 closing price
RIRFX
Price
$73.14
Change
-$0.09 (-0.12%)
Updated
Sep 20 closing price
Ad is loading...

IMACX vs RIRFX

Header iconIMACX vs RIRFX Comparison
Open Charts IMACX vs RIRFXBanner chart's image
Delaware Ivy Multi-Asset Income C
Price$9.83
Change-$0.11 (-1.11%)
VolumeN/A
CapitalizationN/A
American Funds Capital Income Bldr R5
Price$73.14
Change-$0.09 (-0.12%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
IMACX vs RIRFX Comparison Chart
Loading...
VS
IMACX vs. RIRFX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMACX is a StrongBuy and RIRFX is a Buy.

FUNDAMENTALS
Fundamentals
RIRFX has more cash in the bank: 110B vs. IMACX (82.8M). IMACX pays higher dividends than RIRFX: IMACX (4.54) vs RIRFX (3.55). IMACX was incepted earlier than RIRFX: IMACX (9 years) vs RIRFX (22 years). RIRFX is a more actively managed with annual turnover of: 106.00 vs. IMACX (51.00). RIRFX has a lower initial minimum investment than IMACX: RIRFX (250) vs IMACX (1000). RIRFX annual gain was more profitable for investors over the last year : 21.57 vs. IMACX (12.76). RIRFX return over 5 years is better than : 42.88 vs. IMACX (10.13).
IMACXRIRFXIMACX / RIRFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years22 years-
Gain YTD6.06612.83147%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets82.8M110B0%
Annual Yield % from dividends4.543.55128%
Returns for 1 year12.7621.5759%
Returns for 3 years-3.2121.57-15%
Returns for 5 years10.1342.8824%
Returns for 10 yearsN/A55.08-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LBRT20.92-0.16
-0.76%
Liberty Energy
TDY432.13-4.48
-1.03%
Teledyne Technologies
ROOT39.72-0.56
-1.39%
Root
NRXS2.60-0.33
-11.26%
Neuraxis
XBIT6.79-1.16
-14.59%
XBiotech